BioSpace News Archive

UPGRAID Inc., today announced its company, leadership team, and first products aimed at disrupting the traditional health world.

Record-setting demand only increases the American ingenuity and spirit of midwestern company and its associates

Various products can now be used to treat patients experiencing acute respiratory or cardiopulmonary failure

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company with expertise in protein misfolding, announced that today Roche provided an update on Part 1 of the Phase 2 PASADENA study of prasinezumab in patients with early Parkinson’s disease

Exogenesis announces today, the formation of nanoMesh LLC, a medical device company focused on commercialization of the Exogenesis Hernia Mesh (“nanoMesh”), an innovative soft tissue repair implant.

AdventHealth and CHI Franciscan Lead Three-Part Session with Data on Quality and Cost Improvements Achieved Through Electronic Glucose Management WALTHAM, Mass.--( BUSINESS WIRE )-- Glytec , the only provider of insulin management software across the continuum of care, announced today that AdventHealth and CHI Franciscan will lead a three-part session titled, “Computer-Guided Insulin Dosing” at the 2020 Diabetes Technology Society (DTS) Virtual

Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that its first quarter 2020 financial results will be released after market close on Thursday, May 7, 2020.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the pricing of its previously announced underwritten public offering of 45,454,545 common shares, at a public offering price of US$1.10 per share. VBI also granted the underwriters a 30-day option to purchase up to an additional 6

Quantzig, global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has been actively analyzing the current business scenario and the impact of the crisis across industries

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on clinical landscape study for a US-based healthcare company.